Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s stock price shot up 8.6% on Tuesday . The stock traded as high as $42.00 and last traded at $42.00. 313,622 shares were traded during mid-day trading, a decline of 73% from the average session volume of 1,182,351 shares. The stock had previously closed at $38.68.
Wall Street Analysts Forecast Growth
Several research firms have commented on TEM. Morgan Stanley began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective on the stock. William Blair began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued an “outperform” rating on the stock. Stifel Nicolaus began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 price objective on the stock. Needham & Company LLC restated a “buy” rating and issued a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, Loop Capital assumed coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective on the stock. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.56.
Read Our Latest Research Report on TEM
Tempus AI Price Performance
Institutional Trading of Tempus AI
Hedge funds and other institutional investors have recently modified their holdings of the business. Sandia Investment Management LP acquired a new position in Tempus AI in the 2nd quarter valued at about $136,000. Northwestern University acquired a new position in Tempus AI in the 2nd quarter valued at about $491,000. Squarepoint Ops LLC acquired a new position in Tempus AI in the 2nd quarter valued at about $633,000. WINTON GROUP Ltd acquired a new position in Tempus AI in the 2nd quarter valued at about $634,000. Finally, Scientech Research LLC acquired a new position in Tempus AI in the 2nd quarter valued at about $756,000.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
- Five stocks we like better than Tempus AI
- What is an Earnings Surprise?
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- Short Selling: How to Short a Stock
- Jeff Brown’s Exegesis AI Stock Picks
- Canada Bond Market Holiday: How to Invest and Trade
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.